Daniel Mark Schwartz - 29 Jul 2021 Form 3 Insider Report for RxSight, Inc. (RXST)

Role
Director
Signature
/s/ Shelley Thunen, as Attorney-in-Fact
Issuer symbol
RXST
Transactions as of
29 Jul 2021
Net transactions value
$0
Form type
3
Filing time
29 Jul 2021, 10:49:19 UTC
Next filing
05 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RXST Common Stock 414,690 29 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RXST Series C Preferred Stock 29 Jul 2021 Common Stock 3,872 Direct F1
holding RXST Stock Option (right to buy) 29 Jul 2021 Common Stock 4,840 $4.14 Direct F2
holding RXST Stock Option (right to buy) 29 Jul 2021 Common Stock 7,260 $4.14 Direct F2
holding RXST Stock Option (right to buy) 29 Jul 2021 Common Stock 2,904 $4.14 Direct F2
holding RXST Stock Option (right to buy) 29 Jul 2021 Common Stock 179,038 $3.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer will automatically be converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") prior to the closing of the Issuer's initial public offering of its Common Stock.
F2 Shares issued pursuant to the Issuer's 2006 Stock Plan.
F3 Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended.

Remarks:

Exhibit 24 - Power of Attorney